Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | LTRN | KALA | ||
| Company | Orphazyme A/S ADR | Lantern Pharma Inc | Kala Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.9060 | 2.90 | 6.15 | ||
| High | 0.9571 | 2.96 | 6.32 | ||
| Low | 0.8457 | 2.79 | 6.10 | ||
| Last | 0.8700 | 2.91 | 6.41 | ||
| Change | -0.0200 | -0.03 | -0.02 | ||
| % Change | -2.25% | -1.02% | -0.31% | ||
| Volume | 941,400 | 29,212 | 12,912 | ||
| 20-Day Average Volume | 1,980,090 | 49,944 | 32,660 | ||
| Previous Close | 0.8900 | 2.94 | 6.43 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 3.35 | 6.88 | ||
| 20-Day Raw Stochastic | 41.76% | 5.56% | 10.81% | ||
| 20-Day Relative Strength | 36.52% | 37.63% | 47.11% | ||
| Weighted Alpha | -87.89 | -63.09 | -24.49 | ||
| Today's Opinion | 100% Sell | 100% Sell | 24% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 8% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | -18.34% since 11/14/24 | -8.28% since 11/14/24 | ||
| Low | 0.8275 on 03/29/22 | 2.79 on 11/21/24 | 6.00 on 11/20/24 | ||
| High | 0.9600 on 03/29/22 | 3.57 on 11/18/24 | 6.87 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | -15.18% since 10/21/24 | +18.32% since 10/21/24 | ||
| Low | 0.5101 on 03/14/22 | 2.79 on 11/21/24 | 5.15 on 10/22/24 | ||
| High | 1.3720 on 03/10/22 | 3.87 on 11/11/24 | 7.85 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | -35.81% since 08/21/24 | +3.16% since 08/21/24 | ||
| Low | 0.5101 on 03/14/22 | 2.79 on 11/21/24 | 4.95 on 10/17/24 | ||
| High | 2.7500 on 01/03/22 | 4.79 on 08/26/24 | 7.85 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | -54.62% since 05/21/24 | -5.78% since 05/21/24 | ||
| Low | 0.5101 on 03/14/22 | 2.79 on 11/21/24 | 4.21 on 06/26/24 | ||
| High | 5.4900 on 10/13/21 | 6.80 on 05/24/24 | 7.88 on 07/15/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 31,708 | 29,643 | ||
| Shares Outstanding, K | 35,312 | 10,785 | 4,610 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -97,010,000 | -15,960,000 | -42,200,000 | ||
| Last Quarter Sales | N/A | 0 | 0 | ||
| Last Quarter Net Income | N/A | -4,510,000 | -8,950,000 | ||
| 60-Month Beta | 1.68 | 1.58 | -2.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.42 on 11/07/24 | -1.93 on 11/12/24 | ||
| Latest Earnings Date | 04/05/22 | 11/07/24 | 11/11/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||